Sensex: 79,273.33 (-0.95%)

Nifty: 24,378.10 (-0.81%)

anubhai angaldas Securities Pvt. Ltd. Member: BSE - NSE - CDSL

Technology . Transparency . Trust

Contact Us
Apply For IPO

MARKET

IPO Synopsis
Sai Parenteral's Ltd
Registered Office: No.39 5th Flr Lavanya Arcade-, Jayabheri Enclave Gachibowli, Ranga Reddy - 500032, Telangana
Phone: 1
Email: 1
Website: 1
Initial public offer of 10,428,288 equity shares of face value of Rs. 5 each ("Equity Shares") of Sai Parenteral's Limited ("Company" or "Issuer") for cash at a price of Rs. 392 per equity share (Including a Share Premium of Rs. 387 Per Equity Share) ("Offer Price") aggregating to Rs. 408.79 Crore comprising a fresh issue of 7,270,408 equity shares of face value of Rs. 5 each aggregating to Rs. 285 Crore by the company ("Fresh Issue") and an offer for sale of 3,157,880 equity shares of face value of Rs. 5 each aggregating to Rs. 123.79 Crore ("Offered Shares") by investor selling shareholders (such sale, the "Offer For Sale", and together with the fresh issue, the"Offer"). The offer shall constitute 23.60% of the post-offer paid up equity share capital of the company. Price Band: Rs. 392 per equity share of face value of Rs. 5 each. The floor price is 78.40 times the face value of the equity shares. Bids can be made for a minimum of 38 equity shares of face value of Rs. 5 each and in multiples of 38 equity shares of face value of Rs. 5 each thereafter.
Issue Money Payable On
Opens On Closes On Application Allotment
24-Mar-2026 27-Mar-2026 392.00 - 0.00 0.00 - 0.00
Cr. Lead Managers to the Issue
Project Cost 256.50
Project Financed through Current Offer 408.79
Post Issue Equity Share Capital 22.09
Issue Price 392.00
Projects
Capacity expansion and upgradation of manufacturing facilities
Establishment of a new R&D Centre
Repayment / prepayment of certain outstanding borrowings
Working capital requirements
Investment in wholly owned subsidiary, Sai Parenterals Pte Limited (Singapore), in relation to the proposed acquisition of Noumed Pharmaceuticals Pty Limited (Australia)
General corporate purposes
Promoted By
Anil Kumar Karusala
Vijitha Gorrepati
Karusala Aruna
BSE
NSE
Registrar to the Issue
Attention Investor
As per CDSL communiqué Kindly update your Email ID, Mobile Number & Income Range in CDSL demat Account on or before 31st May 2021, Non Compliance Account will be INACTIVE after 31st May 2021. | Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day......................issued in the interest of investors.  | "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account." | "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."    Prevent unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day .......... Issued in the interest of Investors.